Skip Nav Destination
![]()
You do not currently have access to this content.
First TCR T-Cell Therapy Gains Approval
August 9, 2024
Abstract: An autologous T-cell therapy that targets MAGE-A4 with engineered T-cell receptors (TCR) received accelerated approval for the treatment of advanced synovial sarcoma, making it the first TCR-based cell therapy for any solid tumor indication.
RSS Feeds